Short description
EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease
Description
EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will target improving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).
Total funding
$$3123123
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noway Youcantaccess, Noaccess, Uh Ohhhh, Noaccess, Cannot Access, Absolutely Noaccess, Cannot Access, Cannot Access, Noway Youcantaccess, Noway Youcantaccess, Absolutely Noaccess, Noway Youcantaccess, No Way
Sign in for full access
Founders
Anthony DePasqua, Kevin Eggan, Kevin Eggan